Clinical Trials Directory

Trials / Completed

CompletedNCT06106880

Alleviation of Common Cold Symptoms

Alleviation of Upper Respiratory Inflammation and Associated Common Cold Symptoms

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
157 (actual)
Sponsor
Applied Biological Laboratories Inc · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Upper respiratory infections (URIs) have long posed a significant burden to the US healthcare system. Well before the coronavirus disease of 2019 (COVID-19) pandemic they have been among the most common acute outpatient illnesses, causing 75-100 million physician visits each year on average, and costing the health care system billions of dollars annually. This double-blind randomized placebo-controlled study tested the efficacy of two anti-inflammatory throat sprays against placebo and against a throat spray taken in conjunction with 325mg of aspirin, a well-known systemically administered cyclooxygenase (COX) inhibitor. Participants having common cold symptoms lasting less than two days were enrolled and given treatment to administer at home. Various common cold symptoms were assessed and measured via clinically validated self-assessment scales. Participants were screened for influenza and COVID-19 before enrollment and were excluded if found positive.

Conditions

Interventions

TypeNameDescription
DRUGWintergreen Throat Spray and Aspirin TabletThe liquid spray contained wintergreen oil, menthol, lactoferrin, lysozyme, aloe, and glycerin. Aspirin in a 325mg tablet
DRUGAspirin Throat Spray and Placebo TabletThe liquid spray contained 6mg dissolved acetyl salicylic acid per dose, menthol, lactoferrin, lysozyme, aloe, and glycerin. Placebo Tablet: Looked like the treatment aspirin tablet but contained no drug and only inactive excipients.
DIETARY_SUPPLEMENTWintergreen Throat Spray and Placebo TabletThe liquid spray contained wintergreen oil, menthol, lactoferrin, lysozyme, aloe, and glycerin. The placebo tablet looked like the treatment aspirin tablet but contained no drug and only inactive excipients.
OTHERPlacebo Throat Spray and Placebo TabletThe placebo spray contained vehicle buffer, a sub-therapeutic dose of menthol, and a sweetener. The placebo tablet looked like the treatment aspirin tablet but contained no drug and only inactive excipients.

Timeline

Start date
2022-05-25
Primary completion
2023-04-08
Completion
2023-06-16
First posted
2023-10-30
Last updated
2024-01-16

Locations

6 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06106880. Inclusion in this directory is not an endorsement.